No Data
No Data
Theratechnologies Warns of Upcoming Shortage for HIV-Induced Stomach Fat Treatment
Theratechnologies Provides Update on EGRIFTA SV Supply
Sector Update: Health Care Stocks Softer in Late Afternoon Trading
Sector Update: Health Care
Theratechnologies Has Submitted A Prior Approval Supplement To The U.S. FDA Describing The Changes Made To The Manufacturing Environment Of The Facility Where EGRIFTA SV Is Produced
Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV Manufacturing Environment